About TRUVADA
Understanding HIV Therapy
HIV Resources
Paying for TRUVADA
Healthcare Professionals
Learn More
Patient Support Program
HIV Resources Center
Talk To Your Doctor
Full Prescribing Information
Patient Prescribing Information
HIV Specialist
ASO Finder
Zip Code:
Distance:
HIV Specialist
ASO Finder
Zip Code:
Distance:
Add HIV Specialist
REGISTER FOR UPDATES

Register to receive updates about TRUVADA.

Welcome to TRUVADA.com

TRUVADA Is Taken Just Once a Day in Combination Therapy

This section of TRUVADA.com provides information for people who are taking, or who will be taking, TRUVADA as part of their combination HIV therapy. TRUVADA combines two anti-HIV-1 medications, EMTRIVA® (emtricitabine 200 mg) and VIREAD® (tenofovir disoproxil fumarate 300 mg), into one pill that is taken once a day with or without food.

TRUVADA is an anti-HIV-1 drug in the nucleoside reverse transcriptase inhibitor (NRTI or "nuke") family and is always given in combination with other anti-HIV-1 drugs. To learn more about how this once a day HIV-1 treatment is used, click here.

It is important for anyone taking TRUVADA to note that TRUVADA:

  • Does not cure HIV-1 or AIDS
  • Has not been shown to lower your chance of passing HIV-1 to others
  • Should always be taken in combination with other drugs for HIV-1
Plan for Long-Term Success with TRUVADA

Explore TRUVADA.com to find helpful information about managing your HIV, whether you want to:

USE OF TRUVADA

TRUVADA is a type of medicine called an HIV-1 (human immunodeficiency virus) nucleoside analog reverse transcriptase inhibitor and combines EMTRIVA® (emtricitabine) and VIREAD® (tenofovir disoproxil fumarate [DF]) in one pill. TRUVADA is always used with other anti-HIV-1 medicines to treat adults with HIV-1 infection.

TRUVADA does not cure HIV-1 infection or lower your chance of passing HIV-1 to others. TRUVADA should not be used with ATRIPLA® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir DF 300 mg), VIREAD, EMTRIVA, Combivir® (lamivudine/zidovudine), Epivir® or Epivir-HBV® (lamivudine), Epzicom® (abacavir sulfate/lamivudine), or Trizivir® (abacavir sulfate/lamivudine/zidovudine) because these medicines contain the same or similar active ingredients. TRUVADA should not be used with HEPSERA® (adefovir dipivoxil).

IMPORTANT SAFETY INFORMATION

Contact your healthcare provider right away if you experience any of the following side effects or conditions while taking TRUVADA:

  • Nausea, vomiting, unusual muscle pain, and/or weakness. These may be signs of a buildup of acid in the blood (lactic acidosis), which is a serious medical condition
  • Light colored stools, dark colored urine, and/or if your skin or the whites of your eyes turn yellow. These may be signs of serious liver problems (hepatotoxicity), with liver enlargement (hepatomegaly), and fat in the liver (steatosis)
  • If you have HIV-1 and hepatitis B virus (HBV) and stop taking TRUVADA, your liver disease may suddenly get worse. Your healthcare provider will monitor your condition for several months
  • If you have had kidney problems or take other medicines that can cause kidney problems, your healthcare provider should do regular blood tests to check your kidneys
  • Lab tests show changes in the bones of patients treated with VIREAD, a medicine in TRUVADA. If you have had bone problems in the past, talk to your healthcare provider before taking TRUVADA. Also, bone pain and softening of the bone (which may contribute to fractures) may occur as a consequence of kidney problems

Changes in body fat have been seen in some people taking TRUVADA and other anti-HIV-1 medicines.
If you notice any symptoms of infection soon after you start HIV treatment, talk to your doctor right away.

The most common side effects of the medicines in TRUVADA when taken with other anti-HIV-1 medicines are diarrhea, dizziness, nausea, headache, fatigue, abnormal dreams, sleeping problems, rash, depression, and vomiting. Additional side effects are kidney problems (including decline or failure of kidney function), inflammation of the pancreas, inflammation of the liver, allergic reaction, shortness of breath, pain, fatty liver, stomach pain, weakness, indigestion, and intestinal gas. High volume of urine and thirst, muscle pain and muscle weakness due to kidney problems have been reported. Skin discoloration (spots and freckles) may also happen with TRUVADA.

Discuss all medicines you take with your healthcare provider and be aware: Your healthcare provider may need to follow you more closely or adjust your therapy if you are taking Videx® or Videx® EC (didanosine), Reyataz® (atazanavir sulfate), or Kaletra® (lopinavir/ritonavir) with TRUVADA.

Patients should read the Patient Information, including "What is the most important information I should know about TRUVADA?". It is important that you discuss your treatment options and any questions that you may have with your healthcare provider.

*Synovate Healthcare Data; U.S. HIV Monitor, Q1, 2009.
Through 3 years of a clinical study.